With private equity set to further blossom over the next decade and continue its AUM expansion, it will become incumbent upon industry leaders to explore new ways to deliver growth in their firms’ portfolios.
BlackRock Long Term Private Capital will become the new majority shareholder in Creed, the Paris-based multi-century old luxury fragrance company.
Paris-based Apax Partners has added to its team with two new appointments. Joséphine Loréal will work in investor relations, while Raphaël Bazin has been appointed as director at Apax Partners Development, the investment team dedicated to Apax Partners’ investments in companies with a value of EUR10-100 million.
As the consultancy.eu website reported last May, private equity buyout deals in the healthcare sector rose to USD63 billion in 2018, a near 50 per cent year-on-year increase, with North America leading the way. And in Europe, PE healthcare specialist investor Global Healthcare Opportunities (GHO Capital Partners) are tapping in to investor demand; its GHO Capital Fund II, which closed in November 2019, attracted EUR975 million, some 50 per cent larger than its inaugural fund in 2015.
Jerusalem Venture Partners has led a USD5 million funding round in Vicarius for its predictive cyberthreat technology, together with Innovation Hub and Goldbell.
Private equity groups keen to bolster their ‘green’ credentials may wish to consider how they might avail of upcoming Proposed Taxonomy Regulation in Europe, as they seek to standardise, and measure, the real impact of sustainable investments in their portfolios.
As the World Economic Forum celebrates its 50th year, Davos 2020 has the opportunity to transform business via fintech, something which Nigel Green, founder and chief executive of deVere Group, calls the ‘Fourth Industrial Revolution.’
The trend for dedicated funds targeting GP equity stakes is likely to remain strong as investors seek out opportunities in early stage and middle-market PE groups.